Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses". [PDF]
Transl PsychiatryKristensen J.
europepmc +1 more source
India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics. [PDF]
Indian J Psychol MedTom A, Reddy BSC, Sethi MIS, Math SB.
europepmc +1 more source
Pilot study of psilocybin in patients with post-treatment lyme disease. [PDF]
Sci RepGarcia-Romeu A +9 more
europepmc +1 more source
Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. [PDF]
Pharmacol Res PerspectKazdan J, Ladha KS, Husain MI.
europepmc +1 more source
A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations. [PDF]
Ther Adv PsychopharmacolDeutsch A +3 more
europepmc +1 more source
Electrophysiological effects of psilocybin co-administered with midazolam. [PDF]
Transl PsychiatrySutherland MH +10 more
europepmc +1 more source
Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial. [PDF]
BJPsych OpenBeidas Z +11 more
europepmc +1 more source